Pyxis Oncology (PYXS) Change in Account Payables (2020 - 2025)
Pyxis Oncology's (PYXS) quarterly Change in Account Payables came in at $1.1 million in Q4 2025, up 11390.0% year-on-year from N/an in Q4 2024, and up 228.2% on a QoQ basis from $344000.0 in Q3 2025.
Pyxis Oncology (PYXS) Change in Account Payables (2020 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 6 years of Change in Account Payables data on file, last reported at $1.1 million in Q4 2025.
- On a quarterly basis, Change in Account Payables rose 11390.0% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $6.0 million, a 402.17% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 402.17% from the prior year.
- Change in Account Payables for Q4 2025 stood at $1.1 million, up from $344000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for PYXS reached as high as $6.6 million in Q2 2025 and fell as low as -$9.9 million in Q1 2022.
- Historically, Change in Account Payables has averaged $1700.0 across 5 years, with a median of -$228500.0 in 2021.
- Across the five-year window, Change in Account Payables sank 2113.87% in 2022 and surged 11390.0% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $4.0 million in 2021, then sank by 146.74% to -$1.9 million in 2022, then jumped by 118.57% to $350000.0 in 2023, then tumbled by 102.86% to -$10000.0 in 2024, then jumped by 11390.0% to $1.1 million in 2025.
- Per Business Quant data, the three most recent Change in Account Payables figures were $1.1 million in Q4 2025, $344000.0 in Q3 2025, and $6.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.13 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 344,000.00 |
| Sep 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -10,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | -602,000.00 |
| Sep 30, 2024 | -602,000.00 |
| Jun 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 3.18 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Dec 31, 2023 | 350,000.00 |
| Dec 31, 2023 | 350,000.00 |
| Sep 30, 2023 | -1.54 Mn |
| Sep 30, 2023 | -1.54 Mn |